Epstein-Barr Virus Latent Membrane Protein 1 Represses DNA Repair through the PI3K/Akt/FOXO3a Pathway in Human Epithelial Cells

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Virology

• Publication date

  2008-06-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.00430-08PMID 18524825PMCID PMC2519561
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells

  2007cited by this paper
• HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1

  2007cited by this paper
• Ubiquitin proteasome system (UPS): what can chromatin do for you?

  2007cited by this paper
• DDB1 Maintains Genome Integrity through Regulation of Cdt1

  2006cited by this paper
• Epstein-Barr Virus Represses the FoxO1 Transcription Factor through Latent Membrane Protein 1 and Latent Membrane Protein 2A

  2006cited by this paper
• Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancer.

  2006cited by this paper
• Latent Protein LANA2 from Kaposi's Sarcoma-Associated Herpesvirus Interacts with 14-3-3 Proteins and Inhibits FOXO3a Transcription Factor

  2006cited by this paper
• Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae.

  2006cited by this paper
• T‐antigen of the human polyomavirus JC attenuates faithful DNA repair by forcing nuclear interaction between IRS‐1 and Rad51

  2006cited by this paper
• Epstein–Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K

  2005cited by this paper
• HIV-1 accessory protein Vpr inhibits the effect of insulin on the Foxo subfamily of forkhead transcription factors by interfering with their binding to 14-3-3 proteins: potential clinical implications regarding the insulin resistance of HIV-1-infected patients.

  2005cited by this paper
• Epstein–Barr virus latent membrane protein 1 represses p53-mediated DNA repair and transcriptional activity

  2005cited by this paper
• FOXO transcription factors at the interface between longevity and tumor suppression

  2005cited by this paper
• Oncogenic PI3K deregulates transcription and translation

  2005cited by this paper
• Epstein–Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells

  2004influential reference
• Differential Signaling Pathways Are Activated in the Epstein-Barr Virus-Associated Malignancies Nasopharyngeal Carcinoma and Hodgkin Lymphoma

  2004cited by this paper
• Expression of hepatitis C virus core protein impairs DNA repair in human hepatoma cells.

  2004cited by this paper
• Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.

  2004cited by this paper
• Epstein–Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKKα-dependent noncanonical NF-κB activation

  2003cited by this paper
• Latent Membrane Protein 1 of Epstein-Barr Virus Stimulates Processing of NF-κB2 p100 to p52*

  2003cited by this paper
• Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) Activates the Phosphatidylinositol 3-Kinase/Akt Pathway to Promote Cell Survival and Induce Actin Filament Remodeling*

  2003influential reference
• Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.

  2003cited by this paper
• Epstein–Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-κB2 to p52 via an IKKγ/NEMO-independent signalling pathway

  2003cited by this paper
• Two Carboxyl-terminal Activation Regions of Epstein-Barr Virus Latent Membrane Protein 1 Activate NF-κB through Distinct Signaling Pathways in Fibroblast Cell Lines*

  2003cited by this paper
• Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway.

  2003cited by this paper
• DDB complexities.

  2003cited by this paper
• Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52.

  2003cited by this paper
• A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR.

  2002cited by this paper
• DNA Repair Pathway Stimulated by the Forkhead Transcription Factor FOXO3a Through the Gadd45 Protein

  2002cited by this paper
• The role of chromosomal instability in tumor initiation

  2002cited by this paper
• The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability.

  2002cited by this paper
• Genome maintenance mechanisms for preventing cancer

  2001cited by this paper
• LMP1 structure and signal transduction.

  2001cited by this paper
• Epstein-Barr Virus LMP2A Transforms Epithelial Cells, Inhibits Cell Differentiation, and Activates Akt

  2000cited by this paper
• Latent Membrane Protein 2A-Mediated Effects on the Phosphatidylinositol 3-Kinase/Akt Pathway

  2000cited by this paper
• Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses.

  1999cited by this paper
• Defective DNA repair in cells with human T-cell leukemia/bovine leukemia viruses: role of tax gene.

  1999cited by this paper
• An Epstein-Barr Virus That Expresses Only the First 231 LMP1 Amino Acids Efficiently Initiates Primary B-Lymphocyte Growth Transformation

  1999cited by this paper
• Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Activates the JNK Pathway through Its Extreme C Terminus via a Mechanism Involving TRADD and TRAF2

  1999cited by this paper
• Disruption of Nucleotide Excision Repair by the Human T-Cell Leukemia Virus Type 1 Tax Protein

  1999cited by this paper
• Characterization of DNA Recognition by the Human UV-damaged DNA-binding Protein*

  1999influential reference
• The V protein of the paramyxovirus SV5 interacts with damage-specific DNA binding protein.

  1998cited by this paper
• Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice.

  1998cited by this paper
• The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells.

  1998cited by this paper
• Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1)

  1998cited by this paper
• Co-localization of Endogenous and Exogenous p53 Proteins in Nasopharyngeal Carcinoma Cells

  1997cited by this paper
• The Epstein–Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB

  1997cited by this paper
• The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB.

  1997cited by this paper
• Epstein–Barr virus latent membrane protein‐1 triggers AP‐1 activity via the c‐Jun N‐terminal kinase cascade

  1997cited by this paper
• Epstein – Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors

  1997cited by this paper
• Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient X-insertion mutants

  1997cited by this paper
• Latent membrane protein 1 of Epstein–Barr virus mimics a constitutively active receptor molecule

  1997cited by this paper
• The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation.

  1997cited by this paper
• Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1

  1996cited by this paper
• Mutations Specific to the Xeroderma Pigmentosum Group E Ddb− Phenotype*

  1996cited by this paper
• Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation

  1996cited by this paper
• Hepatitis B virus X protein interacts with a probable cellular DNA repair protein

  1995cited by this paper
• The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family.

  1995cited by this paper
• The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.

  1995cited by this paper
• Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.

  1993cited by this paper
• Characterization of seven newly established nasopharyngeal carcinoma cell lines.

  1993cited by this paper
• Induction of micronuclei by HTLV-I Tax: a cellular assay for function.

  1993cited by this paper
• Characterization of a human DNA damage binding protein implicated in xeroderma pigmentosum E.

  1993cited by this paper
• p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features.

  1992cited by this paper
• Epstein-Barr virus.

  1991cited by this paper
• Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6.

  1990cited by this paper
• Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virus

  1990cited by this paper
• Epstein–Barr virus latent membrane protein inhibits human epithelial cell differentiation

  1990cited by this paper
• Establishment and characterization of two nasopharyngeal carcinoma cell lines.

  1990cited by this paper
• Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus.

  1988cited by this paper
• Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA.

  1988cited by this paper
• An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

  1985cited by this paper
• One pyrimidine dimer inactivates expression of a transfected gene in xeroderma pigmentosum cells.

  1985cited by this paper

• The PI3K/Akt Pathway in Herpesvirus Biology: A Double-Edged Sword in Host-Virus Interactions.

  2026cites this paper
• Leaky Artemis Deficiency and EBV‐Related Lymphoproliferative Disease: A Novel Case and Review of the Literature

  2025cites this paper
• Case Report: Angioimmunoblastic T-cell lymphoma with coexisting plasma cell tumors: three cases and review of the literature

  2025cites this paper
• Disruption of ATR Signaling by Epstein–Barr Virus Latent Membrane Protein 1 Sensitizes Nasopharyngeal Carcinoma Cells to Cisplatin

  2025cites this paper
• Regulation mechanism of EBV-encoded EBER1 and LMP2A on YAP1 and the impact of YAP1 on the EBV infection status in EBV-associated gastric carcinoma

  2024cites this paper
• Research Progress of Traditional Drug Therapies for Nasopharyngeal Carcinoma by the PI3K/AKT Signaling Pathway

  2024cites this paper
• Deciphering the Role of Epstein–Barr Virus Latent Membrane Protein 1 in Immune Modulation: A Multifaced Signalling Perspective

  2024cites this paper
• Epidemiology of nasopharyngeal carcinoma: current insights and future outlook

  2024cites this paper
• Comprehensive insight into altered host cell-signaling cascades upon Helicobacter pylori and Epstein–Barr virus infections in cancer

  2023cites this paper
• Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect

  2023cites this paper
• Pioneer factors in viral infection

  2023cites this paper
• The rules and regulatory mechanisms of FOXO3 on inflammation, metabolism, cell death and aging in hosts.

  2023cites this paper
• The role of Epstein–Barr virus in nasopharyngeal carcinoma

  2023cites this paper
• Dietary αKG inhibits SARS CoV-2 infection and rescues inflamed lungs to restore normal O2 saturation in animals

  2022cites this paper
• Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives

  2022cites this paper
• Nasopharyngeal Carcinoma Progression: Accumulating Genomic Instability and Persistent Epstein–Barr Virus Infection

  2022cites this paper
• Novel approach to identify putative Epstein–Barr–virus microRNAs regulating host cell genes with relevance in tumor biology and immunology

  2022cites this paper
• rs9390123 and rs9399451 influence the DNA repair capacity of lung cancer by regulating PEX3 and PHACTR2‑AS1 expression instead of PHACTR2.

  2022cites this paper
• B Cell Receptor-Responsive miR-141 Enhances Epstein-Barr Virus Lytic Cycle via FOXO3 Inhibition

  2021cites this paper
• Tampering of Viruses and Bacteria with Host DNA Repair: Implications for Cellular Transformation

  2021cites this paper
• Virus-induced FoxO factor facilitates replication of human cytomegalovirus

  2021influential citation
• Role of FoxO transcription factors in aging and age-related metabolic and neurodegenerative diseases

  2021cites this paper
• New Look of EBV LMP1 Signaling Landscape

  2021cites this paper
• Viral Modulation of the DNA Damage Response and Innate Immunity: Two Sides of the Same Coin.

  2021cites this paper
• Identification and Characterisation of Human Cytomegalovirus-Mediated Degradation of Helicase-Like Transcription Factor

  2021cites this paper
• Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma

  2021cites this paper
• Multiple Mechanisms Involving in Radioresistance of Nasopharyngeal Carcinoma

  2020cites this paper
• Dysregulation of FOXO transcription factors in Epstein-Barr virus-associated gastric carcinoma.

  2019cites this paper
• Combination Therapy with a PI3K/mTOR Dual Inhibitor and Chloroquine Enhances Synergistic Apoptotic Cell Death in Epstein–Barr Virus-Infected Gastric Cancer Cells

  2019cites this paper
• B Cell Receptor-Responsive miR-141 and viral miR-BART9 promote Epstein-Barr Virus Reactivation Through FOXO3 Inhibition

  2019cites this paper
• Epstein-Barr Virus Latent Membrane Protein 1 Regulates Host B Cell MicroRNA-155 and Its Target FOXO3a via PI3K p110α Activation

  2019cites this paper
• EBV infection is associated with histone bivalent switch modifications in squamous epithelial cells

  2019cites this paper
• The roles of FOX proteins in virus‐associated cancers

  2018cites this paper
• FOXOs Maintaining the Equilibrium for Better or for Worse.

  2018cites this paper
• LIMD1 is induced by and required for LMP1 signaling, and protects EBV-transformed cells from DNA damage-induced cell death

  2017cites this paper
• Epstein–Barr virus infection and nasopharyngeal carcinoma

  2017cites this paper
• EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop

  2016cites this paper
• Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance

  2016cites this paper
• Activation of the DNA Damage Response by RNA Viruses

  2016cites this paper
• EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma.

  2016cites this paper
• Reversible oxidation of phosphatase and tensin homolog (PTEN) alters its interactions with signaling and regulatory proteins.

  2016cites this paper
• EBV reactivation as a target of luteolin to repress NPC tumorigenesis

  2016cites this paper
• Histone H2AX Is Involved in FoxO3a-Mediated Transcriptional Responses to Ionizing Radiation to Maintain Genome Stability

  2015cites this paper
• The role of PI3K/Akt in human herpesvirus infection: From the bench to the bedside.

  2015cites this paper
• Modulation of DNA Damage and Repair Pathways by Human Tumour Viruses

  2015cites this paper
• Epstein–Barr virus BZLF1 protein impairs accumulation of host DNA damage proteins at damage sites in response to DNA damage

  2015cites this paper
• Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma

  2014cites this paper
• Gene expression profiling of Epstein–Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathways

  2014cites this paper
• Epstein-Barr virus and cellular DNA damage response

  2014cites this paper
• Interplay between DNA tumor viruses and the host DNA damage response.

  2013cites this paper
• Optimisation de la radiovirothérapie en associant un traitement radio-isotopique vectorisé par un virus de la rougeole oncolytique, une radiothérapie externe et une inhibition de checkpoint kinase-1

  2013cites this paper
• Intrinsic Immunity

  2013influential citation
• Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications.

  2012cites this paper
• DNA viruses and the cellular DNA-damage response.

  2012cites this paper
• Varicella-Zoster Virus ORF12 Protein Activates the Phosphatidylinositol 3-Kinase/Akt Pathway To Regulate Cell Cycle Progression

  2012cites this paper
• HijAkt

  2012cites this paper
• Pathological alteration of FoxO3a activity promotes idiopathic pulmonary fibrosis fibroblast proliferation on type i collagen matrix.

  2011cites this paper
• Libération extra-cellulaire de microARN et de complexes nucléo-protéiques par les cellules infectées par EBV : rôle des exosomes et d’autres transporteurs

  2011cites this paper
• Dualité fonctionnelle de LMP1 : implication dans l’apoptose et la transformation cellulaire

  2011cites this paper
• Oncolytic viruses in radiation oncology.

  2011cites this paper
• Characterization of FOXO3a as a suppressor of lung adenocarcinoma

  2011cites this paper
• Genomes in conflict: maintaining genome integrity during virus infection.

  2010cites this paper
• Upregulation of Id1 by Epstein-Barr Virus-encoded LMP1 confers resistance to TGFβ-mediated growth inhibition

  2010cites this paper
• Epstein–Barr Virus DNase (BGLF5) induces genomic instability in human epithelial cells

  2009influential citation
• Interaction between viral proteins and hosts and its disturbance in the cellular responses to ionising radiation

  2009cites this paper
• Commentary: mechanistic considerations for associations between formaldehyde exposure and nasopharyngeal carcinoma

  2009cites this paper
• EBV and genomic instability--a new look at the role of the virus in the pathogenesis of Burkitt's lymphoma.

  2009cites this paper
• Three Epstein–Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints

  2009cites this paper
• The Epstein–Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species

  2009influential citation
• In silico analysis of pathways targeted by EBV infection and malignant transformation

  2009influential citation
• ROLE OF LATENT EBV GENES IN THE INDUCTION OF GENOMIC INSTABILITY IN BURKITT'S LYMPHOMA

  2009cites this paper
• Rôle de la protéine LMP1 dans la balance survie/apoptose des cellules infectées par le virus d’Epstein-Barr :

  2008cites this paper